Oxazolidinones: New antibacterial agents
The oxazolidinones are a new chemical class of synthetic antibacterial agents that are active orally or intravenously against multidrug-resistant Gram-positive bacteria. Their unique mechanism of action and activity against bacteria that pose therapeutic problems in hospital and community treatments...
Gespeichert in:
| Veröffentlicht in: | Trends in microbiology (Regular ed.) 1997-05, Vol.5 (5), p.196-200 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 200 |
|---|---|
| container_issue | 5 |
| container_start_page | 196 |
| container_title | Trends in microbiology (Regular ed.) |
| container_volume | 5 |
| creator | Ford, Charles W. Hamel, Judith C. Stapert, Douglas Moerman, Judy K. Hutchinson, Douglas K. Barbachyn, Michael R. Zurenko, Gary E. |
| description | The oxazolidinones are a new chemical class of synthetic antibacterial agents that are active orally or intravenously against multidrug-resistant Gram-positive bacteria. Their unique mechanism of action and activity against bacteria that pose therapeutic problems in hospital and community treatments make them promising candidates for antimicrobial agents. |
| doi_str_mv | 10.1016/S0966-842X(97)01032-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79030994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0966842X97010329</els_id><sourcerecordid>16088263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-b72bf438b3d2c1557da8bdcc8827f5b526a16045b35f99376c39f34a5e02ddc53</originalsourceid><addsrcrecordid>eNqFkEtLAzEUhYMotVZ_QqErqYvRm2QySdyIFF9Q7EIFdyGvkch0piZTX7_e6QO3Xd3FOed-8CE0xHCOARcXTyCLIhM5eR1LfgYYKMnkHupjwUWWUwH7qP9fOURHKb0DAGOE9VBP4gIYiD4az771b1MFF-qm9uly9Oi_Rrpug9G29THoaqTffN2mY3RQ6ir5k-0doJfbm-fJfTad3T1MrqeZzQm0meHElB3dUEcsZow7LYyzVgjCS2YYKXSHzpmhrJSS8sJSWdJcMw_EOcvoAJ1u_i5i87H0qVXzkKyvKl37ZpkUl0BBynxnscN00IJ2RbYp2tikFH2pFjHMdfxRGNRKpVqrVCtPSnK1VqlktxtuAUsz9-5_tXXX5Veb3Hc6PoOPKtnga-tdiN62yjVhB-EP8h6CWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16088263</pqid></control><display><type>article</type><title>Oxazolidinones: New antibacterial agents</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ford, Charles W. ; Hamel, Judith C. ; Stapert, Douglas ; Moerman, Judy K. ; Hutchinson, Douglas K. ; Barbachyn, Michael R. ; Zurenko, Gary E.</creator><creatorcontrib>Ford, Charles W. ; Hamel, Judith C. ; Stapert, Douglas ; Moerman, Judy K. ; Hutchinson, Douglas K. ; Barbachyn, Michael R. ; Zurenko, Gary E.</creatorcontrib><description>The oxazolidinones are a new chemical class of synthetic antibacterial agents that are active orally or intravenously against multidrug-resistant Gram-positive bacteria. Their unique mechanism of action and activity against bacteria that pose therapeutic problems in hospital and community treatments make them promising candidates for antimicrobial agents.</description><identifier>ISSN: 0966-842X</identifier><identifier>EISSN: 1878-4380</identifier><identifier>DOI: 10.1016/S0966-842X(97)01032-9</identifier><identifier>PMID: 9160508</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - pharmacology ; Bacteria - drug effects ; Bacterial Infections - drug therapy ; Community-Acquired Infections - drug therapy ; Cross Infection - drug therapy ; Humans ; Oxazoles - pharmacology ; Oxazolidinones ; Penicillin Resistance</subject><ispartof>Trends in microbiology (Regular ed.), 1997-05, Vol.5 (5), p.196-200</ispartof><rights>1997 Elsevier Science Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-b72bf438b3d2c1557da8bdcc8827f5b526a16045b35f99376c39f34a5e02ddc53</citedby><cites>FETCH-LOGICAL-c420t-b72bf438b3d2c1557da8bdcc8827f5b526a16045b35f99376c39f34a5e02ddc53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0966-842X(97)01032-9$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9160508$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ford, Charles W.</creatorcontrib><creatorcontrib>Hamel, Judith C.</creatorcontrib><creatorcontrib>Stapert, Douglas</creatorcontrib><creatorcontrib>Moerman, Judy K.</creatorcontrib><creatorcontrib>Hutchinson, Douglas K.</creatorcontrib><creatorcontrib>Barbachyn, Michael R.</creatorcontrib><creatorcontrib>Zurenko, Gary E.</creatorcontrib><title>Oxazolidinones: New antibacterial agents</title><title>Trends in microbiology (Regular ed.)</title><addtitle>Trends Microbiol</addtitle><description>The oxazolidinones are a new chemical class of synthetic antibacterial agents that are active orally or intravenously against multidrug-resistant Gram-positive bacteria. Their unique mechanism of action and activity against bacteria that pose therapeutic problems in hospital and community treatments make them promising candidates for antimicrobial agents.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Bacteria - drug effects</subject><subject>Bacterial Infections - drug therapy</subject><subject>Community-Acquired Infections - drug therapy</subject><subject>Cross Infection - drug therapy</subject><subject>Humans</subject><subject>Oxazoles - pharmacology</subject><subject>Oxazolidinones</subject><subject>Penicillin Resistance</subject><issn>0966-842X</issn><issn>1878-4380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtLAzEUhYMotVZ_QqErqYvRm2QySdyIFF9Q7EIFdyGvkch0piZTX7_e6QO3Xd3FOed-8CE0xHCOARcXTyCLIhM5eR1LfgYYKMnkHupjwUWWUwH7qP9fOURHKb0DAGOE9VBP4gIYiD4az771b1MFF-qm9uly9Oi_Rrpug9G29THoaqTffN2mY3RQ6ir5k-0doJfbm-fJfTad3T1MrqeZzQm0meHElB3dUEcsZow7LYyzVgjCS2YYKXSHzpmhrJSS8sJSWdJcMw_EOcvoAJ1u_i5i87H0qVXzkKyvKl37ZpkUl0BBynxnscN00IJ2RbYp2tikFH2pFjHMdfxRGNRKpVqrVCtPSnK1VqlktxtuAUsz9-5_tXXX5Veb3Hc6PoOPKtnga-tdiN62yjVhB-EP8h6CWg</recordid><startdate>19970501</startdate><enddate>19970501</enddate><creator>Ford, Charles W.</creator><creator>Hamel, Judith C.</creator><creator>Stapert, Douglas</creator><creator>Moerman, Judy K.</creator><creator>Hutchinson, Douglas K.</creator><creator>Barbachyn, Michael R.</creator><creator>Zurenko, Gary E.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19970501</creationdate><title>Oxazolidinones: New antibacterial agents</title><author>Ford, Charles W. ; Hamel, Judith C. ; Stapert, Douglas ; Moerman, Judy K. ; Hutchinson, Douglas K. ; Barbachyn, Michael R. ; Zurenko, Gary E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-b72bf438b3d2c1557da8bdcc8827f5b526a16045b35f99376c39f34a5e02ddc53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Bacteria - drug effects</topic><topic>Bacterial Infections - drug therapy</topic><topic>Community-Acquired Infections - drug therapy</topic><topic>Cross Infection - drug therapy</topic><topic>Humans</topic><topic>Oxazoles - pharmacology</topic><topic>Oxazolidinones</topic><topic>Penicillin Resistance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ford, Charles W.</creatorcontrib><creatorcontrib>Hamel, Judith C.</creatorcontrib><creatorcontrib>Stapert, Douglas</creatorcontrib><creatorcontrib>Moerman, Judy K.</creatorcontrib><creatorcontrib>Hutchinson, Douglas K.</creatorcontrib><creatorcontrib>Barbachyn, Michael R.</creatorcontrib><creatorcontrib>Zurenko, Gary E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in microbiology (Regular ed.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ford, Charles W.</au><au>Hamel, Judith C.</au><au>Stapert, Douglas</au><au>Moerman, Judy K.</au><au>Hutchinson, Douglas K.</au><au>Barbachyn, Michael R.</au><au>Zurenko, Gary E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxazolidinones: New antibacterial agents</atitle><jtitle>Trends in microbiology (Regular ed.)</jtitle><addtitle>Trends Microbiol</addtitle><date>1997-05-01</date><risdate>1997</risdate><volume>5</volume><issue>5</issue><spage>196</spage><epage>200</epage><pages>196-200</pages><issn>0966-842X</issn><eissn>1878-4380</eissn><abstract>The oxazolidinones are a new chemical class of synthetic antibacterial agents that are active orally or intravenously against multidrug-resistant Gram-positive bacteria. Their unique mechanism of action and activity against bacteria that pose therapeutic problems in hospital and community treatments make them promising candidates for antimicrobial agents.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>9160508</pmid><doi>10.1016/S0966-842X(97)01032-9</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0966-842X |
| ispartof | Trends in microbiology (Regular ed.), 1997-05, Vol.5 (5), p.196-200 |
| issn | 0966-842X 1878-4380 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79030994 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Anti-Bacterial Agents - pharmacology Bacteria - drug effects Bacterial Infections - drug therapy Community-Acquired Infections - drug therapy Cross Infection - drug therapy Humans Oxazoles - pharmacology Oxazolidinones Penicillin Resistance |
| title | Oxazolidinones: New antibacterial agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A22%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxazolidinones:%20New%20antibacterial%20agents&rft.jtitle=Trends%20in%20microbiology%20(Regular%20ed.)&rft.au=Ford,%20Charles%20W.&rft.date=1997-05-01&rft.volume=5&rft.issue=5&rft.spage=196&rft.epage=200&rft.pages=196-200&rft.issn=0966-842X&rft.eissn=1878-4380&rft_id=info:doi/10.1016/S0966-842X(97)01032-9&rft_dat=%3Cproquest_cross%3E16088263%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16088263&rft_id=info:pmid/9160508&rft_els_id=S0966842X97010329&rfr_iscdi=true |